Literature DB >> 4075589

Class and subclass anti-pneumococcal antibody responses in splenectomized patients.

S Oldfield, S Jenkins, H Yeoman, D Gray, I C MacLennan.   

Abstract

Antibody titres against pneumococcal capsular and cell wall antigens and the immune response to polyvalent pneumococcal vaccine were measured in 21 splenectomized patients and 12 healthy controls. Most individuals possessed anti-pneumococcal capsular polysaccharide antibodies of IgG, IgA and IgM classes. The anti-capsular IgG was predominantly of the IgG1 and IgG2 subclasses; only occasional individuals had any detectable titre in IgG3 or IgG4 subclass. Most individuals responded to immunization with Pneumovax. There was no clear difference between groups of control and splenectomized subjects, although three of the splenectomized patients had undetectable pre-immunization anti-capsular titres in one or more subclass which failed to rise following immunization. All subjects tested had anti-phosphocholine antibodies in IgG, IgA and IgM classes with the exception of a single splenectomized patient who lacked detectable anti-phosphocholine IgM. Pre-immunization titres where similar in healthy controls and splenectomized patients. There was no demonstrable rise in anti-phosphocholine titre following immunization with Pneumovax.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4075589      PMCID: PMC1577272     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy.

Authors:  H KING; H B SHUMACKER
Journal:  Ann Surg       Date:  1952-08       Impact factor: 12.969

2.  Hyposplenism and overwhelming pneumococcal infection: a reappraisal.

Authors:  A L Bisno
Journal:  Am J Med Sci       Date:  1971-08       Impact factor: 2.378

3.  Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens.

Authors:  G R Siber; P H Schur; A C Aisenberg; S A Weitzman; G Schiffman
Journal:  N Engl J Med       Date:  1980-07-24       Impact factor: 91.245

4.  Immunologic memory to phosphorylcholine in vitro. I. Asymmetric expression of clonal dominance.

Authors:  S P Chang; M B Rittenberg
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

5.  Natural infection of man with group A streptococci. Levels; restriction in class, subclass, and type; and clonal appearance of polysaccharide-group-specific antibodies.

Authors:  W F Riesen; F Skvaril; D G Braun
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

6.  Failure of pneumococcal vaccination in a splenectomized child.

Authors:  J Lanng Nielsen; F Karup Pedersen; J Ellegaard
Journal:  Acta Paediatr Scand       Date:  1982-03

7.  Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate.

Authors:  D E Brundish; J Baddiley
Journal:  Biochem J       Date:  1968-12       Impact factor: 3.857

8.  Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types.

Authors:  S C Szu; S Clarke; J B Robbins
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  Immune response after splenectomy.

Authors:  J L Sullivan; H D Ochs; G Schiffman; M R Hammerschlag; J Miser; E Vichinsky; R J Wedgwood
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

10.  Antibody response and opsonization afer pneumococcal vaccination in splenectomized children and healthy persons.

Authors:  K S Johansen; F K Pedersen
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1982-10
View more
  9 in total

1.  Impaired IgG2 anti-pneumococcal antibody responses in patients with recurrent infection and normal IgG2 levels but no IgA.

Authors:  P J Lane; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

2.  Immune status and response to immunization with polysaccharide vaccines of a healthy, congenitally asplenic woman.

Authors:  P J McElroy; F I Henderson; D L Brown
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

3.  Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for response criteria.

Authors:  M J Rodrigo; M Miravitlles; M J Cruz; J de Gracia; M Vendrell; C Pascual; F Morell
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

4.  The role of the spleen in the immune response following naturally acquired exposure to encapsulated bacteria.

Authors:  R J Holdsworth; H McKenzie; D Parratt; A D Irving; A Cuschieri
Journal:  Int J Exp Pathol       Date:  1990-12       Impact factor: 1.925

5.  Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation.

Authors:  J E Lortan; A Vellodi; E S Jurges; K Hugh-Jones
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

6.  Splenic autotransplantation and the immune system. Adequate testing required for evaluation of effect.

Authors:  W Timens; R Leemans
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

Review 7.  Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations.

Authors:  G A Bruyn; R van Furth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

8.  Development of anti-polysaccharide antibodies in asplenic children.

Authors:  L Hammarström; C I Smith
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

9.  The influence of genetic factors on the immune response as judged by pneumococcal vaccination of mono- and dizygotic Caucasian twins.

Authors:  H B Konradsen; J Henrichsen; H Wachmann; N Holm
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.